Literature DB >> 22017039

Coexpression of avian influenza virus H5 and N1 by recombinant Newcastle disease virus and the impact on immune response in chickens.

Kristina Ramp1, Jutta Veits, Daniela Deckers, Miriam Rudolf, Christian Grund, Thomas C Mettenleiter, Angela Römer-Oberdörfer.   

Abstract

To analyze the contribution of neuraminidase (NA) toward protection against avian influenza virus (AIV) infection, three different recombinant Newcastle disease viruses (NDVs) expressing hemagglutinin (HA) or NA, or both, of highly pathogenic avian influenza virus (HPAIV) were generated. The lentogenic NDV Clone 30 was used as backbone for the insertion of HA of HPAIV strain A/chicken/Vietnam/P41/05 (H5N1) and NA of HPAIV strain A/duck/Vietnam/TG24-01/05 (H5N1). The HA was inserted between the genes encoding NDV phosphoprotein (P) and matrixprotein (M), and the NA was inserted between the fusion (F) and hemagglutinin-neuraminidase protein (HN) genes, resulting in NDVH5VmPMN1FHN. Two additional recombinants were constructed carrying the HA gene between the NDV P and M genes (NDVH5VmPM) or the NA between F and HN (NDVN1FHN). All recombinants replicated well and stably expressed the HA gene, the NA gene, or both. Chickens immunized with NDVH5VmPMN1FHN or NDVH5VmPM were protected against two different HPAIV H5N1 and also against HPAIV H5N2. In contrast, immunization of chickens with NDVN1FHN induced NDV- and AIV N1-specific antibodies but did not protect the animals against a lethal dose of HPAIV H5N1. Furthermore, expression of AIV N1, in addition to AIV H5 by NDV, did not increase protection against HPAIV H5N1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22017039     DOI: 10.1637/9652-011111-Reg.1

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  10 in total

1.  Biological and protective properties of immune sera directed to the influenza virus neuraminidase.

Authors:  Stefan J Halbherr; Thomas H Ludersdorfer; Meret Ricklin; Samira Locher; Marianne Berger Rentsch; Artur Summerfield; Gert Zimmer
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Chimeric newcastle disease virus protects chickens against avian influenza in the presence of maternally derived NDV immunity.

Authors:  Constanze Steglich; Christian Grund; Kristina Ramp; Angele Breithaupt; Dirk Höper; Günther Keil; Jutta Veits; Mario Ziller; Harald Granzow; Thomas C Mettenleiter; Angela Römer-Oberdörfer
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

3.  Different regions of the newcastle disease virus fusion protein modulate pathogenicity.

Authors:  Sandra Heiden; Christian Grund; Anja Röder; Harald Granzow; Denis Kühnel; Thomas C Mettenleiter; Angela Römer-Oberdörfer
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

4.  Viral vector vaccines expressing nucleoprotein and phosphoprotein genes of avian bornaviruses ameliorate homologous challenge infections in cockatiels and common canaries.

Authors:  Marita Olbert; Angela Römer-Oberdörfer; Christiane Herden; Sara Malberg; Solveig Runge; Peter Staeheli; Dennis Rubbenstroth
Journal:  Sci Rep       Date:  2016-11-10       Impact factor: 4.379

Review 5.  Influenza Neuraminidase Characteristics and Potential as a Vaccine Target.

Authors:  Sarah Creytens; Mirte N Pascha; Marlies Ballegeer; Xavier Saelens; Cornelis A M de Haan
Journal:  Front Immunol       Date:  2021-11-16       Impact factor: 7.561

6.  Generation and Evaluation of Recombinant Thermostable Newcastle Disease Virus Expressing the HA of H9N2 Avian Influenza Virus.

Authors:  Xiaorong Zhang; Zongyi Bo; Chenchen Meng; Yin Chen; Chengcheng Zhang; Yongzhong Cao; Yantao Wu
Journal:  Viruses       Date:  2021-08-13       Impact factor: 5.048

7.  Newcastle disease virus expressing an angiogenic inhibitor exerts an enhanced therapeutic efficacy in colon cancer model.

Authors:  Fanrui Meng; Yukai Cao; Han Su; Tianyan Liu; Limin Tian; Yu Zhang; Jiarui Yang; Wei Xiao; Deshan Li
Journal:  PLoS One       Date:  2022-04-05       Impact factor: 3.240

Review 8.  Virus-vectored influenza virus vaccines.

Authors:  Ralph A Tripp; S Mark Tompkins
Journal:  Viruses       Date:  2014-08-07       Impact factor: 5.048

Review 9.  Viral vector-based influenza vaccines.

Authors:  Rory D de Vries; Guus F Rimmelzwaan
Journal:  Hum Vaccin Immunother       Date:  2016-07-25       Impact factor: 3.452

10.  Expression of Two Foreign Genes by a Newcastle Disease Virus Vector From the Optimal Insertion Sites through a Combination of the ITU and IRES-Dependent Expression Approaches.

Authors:  Lei He; Zhenyu Zhang; Qingzhong Yu
Journal:  Front Microbiol       Date:  2020-04-28       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.